Betamethasone Ointment Augmented

Name: Betamethasone Ointment Augmented

Indications and Usage for Betamethasone Ointment Augmented

Betamethasone dipropionate ointment (augmented), 0.05% is a corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses in patients 13 years of age or older.

Betamethasone Ointment Augmented Description

Betamethasone Dipropionate Ointment USP (Augmented), 0.05% contains betamethasone dipropionate USP, a synthetic adrenocorticosteroid, for topical use. Betamethasone, an analog of prednisolone, has a high degree of corticosteroid activity and a slight degree of mineralocorticoid activity. Betamethasone dipropionate is the 17,21-dipropionate ester of betamethasone.

Chemically, betamethasone dipropionate is 9-fluoro-11β,17,21-trihydroxy-16β-methylpregna-1,4-diene-3,20-dione 17,21-dipropionate, with the molecular formula C28H37FO7, a molecular weight of 504.6 and the following structural formula:

Betamethasone dipropionate is a white to creamy-white, odorless powder insoluble in water; freely soluble in acetone and in chloroform; sparingly soluble in alcohol.

Each gram of Betamethasone Dipropionate Ointment USP (Augmented), 0.05% contains: 0.643 mg betamethasone dipropionate, USP (equivalent to 0.5 mg betamethasone) in a white to off-white ointment base of propylene glycol, propylene glycol monostearate, beeswax and white petrolatum.

PRINCIPAL DISPLAY PANEL - 15 g Tube

NDC 0168-0268-15

Fougera®

  BETAMETHASONE
DIPROPIONATE OINTMENT
USP (AUGMENTED), 0.05%*
*Strength expressed as betamethasone

Rx only

  For topical use only.
Not for oral, ophthalmic, or
intravaginal use.

NET WT 15 grams

(web3)